✦ LIBER ✦

Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product

✍ Scribed by W.Roy Smythe; Imran Mohuiddin; Mustafa Ozveran; Xiaobo X. Cao

Book ID: 114490499
Publisher: CTSNet
Year: 2002
Tongue: English
Weight: 791 KB
Volume: 123
Category: Article
ISSN: 1097-685X
DOI: 10.1067/mtc.2002.121684

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bcl-xL antisense oligonucleotide and cis

Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts

✍ James E. Littlejohn; Xiaobo Cao; Steven D. Miller; Mustafa K. Ozvaran; Daniel Ju 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 702 KB

## Abstract Bcl‐xL functions as a dominant regulator of apoptotic cell death and is implicated in chemotherapeutic resistance of malignant pleural mesothelioma (MPM). Mesothelioma cell lines demonstrate increasing levels of Bcl‐xL as resistant clones are selected __invitro__. Moreover, upon introdu

Targeted Correction of the Point Mutatio

Targeted Correction of the Point Mutations of β-Thalassemia and Targeted Mutagenesis of the Nucleotide Associated with HPFH by RNA/DNA Oligonucleotides: Potential for β-Thalassemia Gene Therapy

✍ Zhu-Hong Li; De-Pei Liu; Wen-Xuan Yin; Zhi-Chen Guo; Chih-Chuan Liang 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 326 KB